2018 대한부정맥학회 비판막성 심방세동 환자의 뇌졸중 예방 지침
-
DOI: https://doi.org/10.3904/kjm.2018.93.2.87.e1
2018 대한부정맥학회 비판막성 심방세동 환자의 뇌졸중 예방 지침
-
이정명1, 정보영2, 차명진3, 이지현4, 임우현5, 김태훈2, 신승용6, 엄재선2, 임홍의7, 김진배1, 김준수8
2018 KHRS Guidelines for Stroke Prevention Therapy in Korean Patients with Nonvalvular Atrial Fibrillation
-
Jung Myung Lee1, Boyoung Joung2, Myung-Jin Cha3, Ji Hyun Lee4, Woo Hyun Lim5, Tae-Hoon Kim2, Seung Yong Shin6, Jae-Sun Uhm2, Hong Euy Lim7, Jin-Bae Kim1, Jun Soo Kim8
-
Copyright © 2018 The Korean Association of Internal Medicine
다음과 같이 본문 내 Table 5에 오류가 있어 수정합니다.
Table 5.
Guidance for temporary interruption of NOAC before surgery
|
Dabigatran
|
Apixaban, edoxaban, rivaroxaban
|
Low-risk surgery |
High-risk surgery |
|
Low-risk surgery |
High-risk surgery |
Creatinine clearance >80 mL/min |
24 hours |
48 hours |
24 hours |
48 hours |
Creatinine clearance 50-80 mL/min |
36 hours |
72 hours |
24 hours |
48 hours |
Creatinine clearance 30-50 mL/min |
48 hours |
96 hours |
24 hours |
48 hours |
Creatinine clearance 15-30 mL/min |
Not indicated |
Not indicated |
36 hours |
48 hours |
Table 5.
Guidance for temporary interruption of NOAC before surgery
|
Dabigatran
|
Apixaban, edoxaban, rivaroxaban
|
Low risk surgery |
High risk surgery |
Low risk surgery |
High risk surgery |
Creatinine clearance >80 mL/min |
24 hours |
48 hours |
24 hours |
48 hours |
Creatinine clearance 50-80 mL/min |
36 hours |
72 hours |
24 hours |
48 hours |
Creatinine clearance 30-50 mL/min |
48 hours |
96 hours |
24 hours |
48 hours |
Creatinine clearance 15-30 mL/min |
Not indicated |
Not indicated |
36 hours |
48 hours |